Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Rubinstein Julie sold 69,061 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Apr 17 to Apr 21, 2026 · Filed Apr 21, 2026

From Apr 17 to Apr 21, 2026, Rubinstein Julie (President and COO) sold 69,061 Adaptive Biotechnologies Corporation shares at an average US$14.60 for US$1.01M under a trading plan, leaving 395,146 shares. Filed Apr 21, 2026 (Form 4).

Sold
69,061 shares
Price
US$14.60 average (US$14.55 to US$14.66)
Value
US$1.01M
Holding after
395,146 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President and COO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 17, 2026Common StockOption exercise14,722US$8.46422,882Direct
Apr 17, 2026Common StockSale19,060US$14.57403,822Direct
Apr 20, 2026Common StockOption exercise14,722US$8.46418,544Direct
Apr 20, 2026Common StockSale19,060US$14.55399,484Direct
Apr 21, 2026Common StockOption exercise14,722US$8.46414,206Direct
Apr 21, 2026Common StockOption exercise11,881US$12.14426,087Direct
Apr 21, 2026Common StockSale30,941US$14.66395,146Direct

Source

View original at SEC

Related